Risk of progression and the cause of mortality at chronic viral mixed-hepatitis
Abstract
Aim of investigation. To estimate risk of development of liver function decompensation, hepatocellular carcinoma (HCC) development and prognostic factors of liver-related mortality in patients with chronic viral mixed-hepatitis.
Material and methods. 82 patients with hepatitis D, 56 – with hepatitis B+C and 20 – with hepatitis B+C+D, followed-up from Jan 2002 to Dec 2011, were included in the study. Results. During follow-up, decompensation occurred in 45.1, 8.9 and 62.5% of patients with compensated liver cirrhosis in groups D, BC and BCD, respectively. The 5-year risk of decompensation was 62%, 27% and 60%. HCC developed in 5.7% of patients, high AFP being the only predictor of HCC. The 5-year risk of HCC was 3.8%, 3.5% and 0%, respectively. 17.1%, 1.8% and 20% of patients died in groups D, BC and BCD, respectively, 5-year survival rate was 90%, 97% and 82%.
Conclusions. In patients with chronic viral mixed hepatitis it is decompensation with liver failure development that determines prognosis and is principal cause of liver-related mortality in the most cases, not HCC development.
About the Authors
K. I. Yesmembetov
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
D. T. Abdurakhmanov
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
A. V. Odintsov
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
N. A. Mukhin
State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university», Ministry of Healthcare of the Russian Federation
Russian Federation
Russian Federation
References
1. Абдурахманов Д.Т. Хронический гепатит В и D. – М.: Гэотар-медиа, 2010. – 296 с.
2. Абдурахманов Д.Т., Крель П.Е., Лопаткина Т.Н. и др. Хронический гепатит D: клиническая характеристика, течение и прогноз // Клин. гепатол. – 2010. – № 1. – С. 47–50.
3. Сюткин В.Е. Клиническая характеристика хронических диффузных заболеваний печени, обусловленных сочетанной инфекцией вирусами гепатита В, С и/или дельта: Автореф. дис. ... канд. мед. наук. – М., 1999.
4. Chu C.J., Lee S.D. Hepatitis B virus/hepatitis C virus coinfection: Epidemiology, clinical features, viral interactions and treatment // J. Gastroenterol. Hepatol. – 2008. – 23 (4). – Р. 512–20.
5. Crockett S.D., Keeffe E.B. Natural history and treatment of hepatitis B virus and hepatitis C virus coinfection // Ann. Clin. Microbiol. Antimicrob. – 2005. – Sep. – Р. 4–13.
6. Fattovich G., Giustina G., Christensen E. et al. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B // Gut. –2000. – Vol. 46. – P. 420–426.
7. Gaeta G.B., Stornaiuolo G., Precone D.F. et al. Epidemiological and clinical burden of chronic hepatitis B virus/hepatitis C virus infection. A multicenter Italian study // J. Hepatol. – 2003. – Vol. 39. – P. 1036–1041.
8. Gheorghe L., Iacob S., Simionov I. et al. Natural history of compensated viral B and D cirrhosis // Rom. J. Gastroenterol. – 2005. – Vol. 14 (4). – P. 329–335.
9. Liaw Y.F., Chen Y.C., Sheen I.S. et al. Impact of acute hepatitis C virus superinfection in patients with chronic hepatitis B virus infection // Gastroenterology. – 2004. – Vol. 126. – P. 1024–1029.
10. Peters M.G. Special populations with hepatitis B virus infection // Hepatology. – 2009. – Vol. 49 (suppl. 5). – P. 146–155.
11. Rizzetto M. Hepatitis D: thirty years after // J. Hepatol. – 2009. – Vol. 50 (5). – P. 1043–1050.
12. Romeo R., del Ninho E., Rumi M. et al. A 28-year study of the course of HDV infection: a risk factor for cirrhosis and HCC // Gastroenterology. – 2009. – Vol. 136. – P. 1629–1638.
13. Su C.W., Huang Y.H., Huo T.I. et al. Genotypes and viremia of hepatitis B and D viruses are associated with outcomes of chronic hepatitis D patients // Gastroenterology. – 2006. – Vol. 130 (6). – P. 1625–1635.
Review
For citations:
Yesmembetov K.I., Abdurakhmanov D.T., Odintsov A.V., Mukhin N.A. Risk of progression and the cause of mortality at chronic viral mixed-hepatitis. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2013;23(3):49-55. (In Russ.)
Views:
89
Email this article 
